- It is launched for developing countries who are the members of ADB.
- The APVAX is basically $9 billion initiative which will help developing member nations of ADB to procure and deliver coronavirus vaccines.
- This initiative will offer rapid and equitable support for procurement and delivery of COVID-19 vaccines.
- The APVAX will help to meet and tackle challenges faced due to pandemic and to focus on economic recovery.
- Also, ADB is planning to make available COVID-19 vaccine import facility to its member's nations.
- The APVAX initiative is based on 2 main components namely: Rapid Response Component and Project Investment Component.
- Static Part:
- HQ of ADB: Mandaluyong, Metro Manila, Philippines
- President of ADB: Masatsugu Asakawa
Question:
Q.1 Who among the following launched Asia Pacific Vaccine Access Facility (APVAX)?
a. Asian Development Bank
b. South Asian Association for Regional Cooperation
c. Organisation for Economic Co-operation and Development
d. BRICS
Q.2 What is the amount for ADB’s Asia Pacific Vaccine Access Facility (APVAX) initiative?
a. $8 billion
b. $10 billion
c. $7 billion
a. Asian Development Bank
b. South Asian Association for Regional Cooperation
c. Organisation for Economic Co-operation and Development
d. BRICS
Q.2 What is the amount for ADB’s Asia Pacific Vaccine Access Facility (APVAX) initiative?
a. $8 billion
b. $10 billion
c. $7 billion
d. $9 billion
